Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

GREY:LXXGQ - Post Discussion

Lexagene Holdings Inc > WCVB Boston tonight COVID-19 Story
View:
Post by EduardoSanchez on Mar 03, 2020 5:31pm

WCVB Boston tonight COVID-19 Story

Tune in tonight to WCVB Boston to see #LexaGene featured as part of their news reporting on #COVID19 #coronavirus

Comment by greenlant59 on Mar 04, 2020 2:09pm
To market in August. BEVERLY, Mass. — A Massachusetts company is looking to bring testing for COVID-19, the coronavirus, out of laboratories and into places such as hospitals and airports. Dr. Jack Regan, the chief executive officer of Beverly-based LexaGene, said state laboratory results for COVID-19 -- which state health officials said could be turned around in 24 hours -- take ...more  
Comment by 007dave on Mar 04, 2020 2:45pm
He said his company is developing a testing instrument, the LX2, that could yield results on a COVID-19 sample much more quickly than a government laboratory. That was a good news piece on LXG. I Dr Regan is a very bright man but could be more of a salesman. " Is developing" I thought they HAVE developed a testing instrument and "could yield results" am I wrong or have they ...more  
Comment by EduardoSanchez on Mar 04, 2020 5:21pm
I think he is just being cautious as they are still finalizing the commercial version of the LX Analyzer. Some more info from the WCVB story is the anticipated cost for the LX2 in the 20k range. This is down from the original estimates of 40-50k  The lower cost significantly lowers the pay off period for customers and should help accelerate adoption. 
Comment by 007dave on Mar 04, 2020 6:04pm
I understand being cautious. But just state facts. Yes we have a commercially available machine that is capable of a test for Coronavirus. The LX has proven what it can do. And whether a few minor tweaks are being finalized the machine is essentially ready to be manufactured and available by summer.
Comment by ragb7002 on Mar 05, 2020 11:35am
YOU THINK SO?
Comment by ragb7002 on Mar 05, 2020 11:41am
NR HAS DONE NOTHING FOR THE "SP" As you said Dr.Reagan any thing but a salesman or business man. Stock has languished for years. No interest!!
Comment by 007dave on Mar 05, 2020 12:17pm
Like i said he is a brilliant scientist. His job is not to be a salesman or deal with the business side. His job is to be the technical talking head. Speak to all the other smart people in government agencies, at conferences, talk on all technical aspects and future potential of the LX2. The business side falls on the president Daryl Rebeck. He was brought in because of his years of experience in ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities